[1]
“IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF SURVIVAL OUTCOMES AND ADVERSE EVENTS”, FMHR, vol. 4, no. 5, pp. 871–886, May 2026, Accessed: May 26, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/2945